查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗體發現市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按抗體類型、性質、服務、最終用戶和地理位置
市場調查報告書
商品編碼
1463827

抗體發現市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按抗體類型、性質、服務、最終用戶和地理位置

Antibody Discovery Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Antibody Type, Nature, Service, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 180 Pages | 訂單完成後即時交付

價格

抗體發現市場規模預計將從 2022 年的 29.4 億美元激增至 2030 年的 49.2 億美元；預計 2022 年至 2030 年市場複合年成長率為 6.7%。研發投資的增加和癌症發生率的上升推動了抗體發現市場的成長。

以生物製品為重點的生物製藥行業的擴張導致對抗體研究服務的需求比以前更高。產業參與者和學術機構之間加強合作促進資源共享並加速抗體發現。向以患者為中心的藥物開發的轉變，強調個人化醫療和患者偏好，推動了抗體發現市場的發展。

高通量篩選、噬菌體展示和下一代定序等持續的技術進步提高了抗體發現過程的效率和速度。政府組織和私人企業對研發活動的資助增加也刺激了抗體發現計畫。單株抗體由於其針對特定抗原的特異性和有效性而在治療應用中越來越受歡迎，導致對抗體研究服務的需求增加。因此，對抗體療法的需求不斷成長以及對外包的偏好可能會對未來幾年的抗體發現市場預測產生重大影響。

癌症發生率上升推動抗體發現市場

根據全球癌症觀察站 (GLOBOCAN) 2020 年發布的估計，全球有 1,930 萬癌症病例。美國、中國和印度的病例數明顯較高。 GLOBOCAN 進一步資料，到 2040 年，印度的癌症病例將達到約 208 萬例，較 2020 年增加 57.5%。全世界的癌症。根據美國癌症協會的報告，自 2019 年 1 月以來，約有 1,690 萬有癌症史的人居住在美國。化。肺癌、乳癌、大腸癌、攝護腺癌和乳癌是最常見的癌症類型。癌症發生率的上升引起了全世界的關注。以下是 2020 年全球報告的常見癌症病例清單。

  • 表 1. 2020 年全球新癌症病例

Sr. No.癌症類型 病例數（百萬）

1胃1.09

2皮膚（非黑色素瘤）1.2

3前列腺1.41

4結腸和直腸1.93

5肺2.21

6乳房2.26

資料來源：世界衛生組織，2020 年 2 月

癌症現在是一種生活方式疾病，常見於飲食習慣不健康和缺乏體能活動的人。經常飲酒和吸煙會增加患這種疾病的風險。低收入和中等收入國家的慢性傳染病可進一步加劇癌症危險因子。癌症發生率的激增表明需要創新的癌症治療方法。單株抗體是一類有前景的標靶抗癌藥物，可增強免疫系統抑制癌細胞活性和消除癌細胞的天然能力。抗體藥物偶聯物（ADC）在癌症治療中也顯示出有希望的結果。此外，現代生物技術的進步使研究人員和公司能夠提供精心設計的新型抗體，為成功治療各種類型的癌症鋪平道路。因此，不同類型癌症發生率的迅速上升促進了抗體發現市場的成長。

市場趨勢

客製化抗體的開發

抗體是不可或缺的研究工具，使各個科學領域的研究人員能夠指定、識別、定位和量化其蛋白質標靶。醫療技術的進步為更快、更有效率地發現根據客戶要求量身定做的抗體提供了支持。將生物資訊整合到抗體的發現中引發了客製化抗體研究的進步。人工智慧 (AI) 有潛力成為客製化抗體發現過程中必不可少的增值工具。 AI 和機器學習 (ML) 演算法分析大型資料集、預測抗體-抗原交互作用並最佳化抗體特性。這些技術還可以幫助設計、篩選和先導化合物最佳化；識別模式；預測結合親和力；並對候選抗體進行優先排序以進行進一步表徵。除了有效分析和解釋大規模抗體篩選資料的需求之外，巨量資料分析解決方案的可用性不斷增加和運算能力的進步也推動了人工智慧和機器學習的使用。人工智慧和機器學習技術的整合有可能提高抗體發現計畫的成功率，並促進更有效的治療性抗體的開發。

客製化單株抗體的使用是腫瘤學研究中一個有吸引力的領域。大多數的臨床試驗是使用源自兔子的單株抗體進行。例如，抗VEGF，一種人源化抗血管生長內皮因子（兔單株抗體），目前正在進行臨床研究，以評估其對轉移性結直腸癌和其他實體腫瘤的作用。同樣，抗 VEGF 藥物正在臨床研究中用於治療老年黃斑部病變。兔源性單株抗體已被證明是比小鼠源性單株抗體更好的替代品，因為其抗原結合位點具有更大的互補決定區 (CDR)。此外，單株抗體可用於產生更高親和力的克隆。例如，Creative Biolabs 提供各種客製化多克隆和單株抗體生產服務，從基因表現或胜肽合成到抗體純化和標記。因此，在預測期內，客製化單株抗體很可能成為抗體發現市場的獲利趨勢。

「全球抗體發現市場」根據抗體類型、性質、服務、最終用戶和地理位置進行細分。

基於抗體類型的見解

依產品類型，抗體發現市場分為單株抗體、多株抗體等。單株抗體細分市場將在 2022 年佔據更大的市場佔有率。

單株抗體 (mAb) 旨在與患病細胞特異性相互作用，而不傷害健康細胞。癌症治療是使用單株抗體的重要應用領域之一。這些是被廣泛接受的生物製劑，預計在預測期內將為製藥商帶來高價值的機會。此外，患者和醫生對單株抗體療法應用的認知顯著提高。因此，用於治療各種適應症的重磅單株抗體的批准預計將有利於預測期內抗體發現市場的成長。 Avastin、Herceptin、Remicade、Rituxan 等多種藥物已被 FDA 核准用於治療癌症、類風濕性關節炎、克隆氏症、潰瘍性結腸炎等。

基於最終用戶的見解

根據最終用戶，抗體發現市場分為製藥和生技公司、研究實驗室等。製藥和生物技術公司細分市場在 2022 年佔據最大的抗體發現市場佔有率，預計該細分市場在 2022 年至 2030 年期間的複合年成長率將達到 7.2%。

製藥和生物技術公司在抗體發現過程中佔據重要地位，因為它們有能力識別任何特定疾病的抗體並以商業規模生產它們。藥物發現和開發對高特異性抗體的需求不斷增加；蛋白質體學和基因組學領域的研究不斷發展；對抗體辨識新標靶和檢測方法的需求不斷增加；癌症、愛滋病毒/愛滋病、免疫缺陷疾病和血液疾病等多個治療領域不斷增加的研發活動是推動製藥和生物技術公司對抗體發現產品、解決方案和服務需求的關鍵因素。

美國食品藥物管理局、疾病預防控制中心、全球癌症觀測站、世界衛生組織、經濟合作暨發展組織、厚生勞動省、食品藥物安全部、生物醫學高級研究與開發權威機構（BARDA）正在準備抗體發現市場研究報告時所引用的一些相關來源。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解
  • 抗體發現市場（按地理位置）

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：抗體發現市場格局

  • 概述
  • 全球PEST分析

第 5 章：抗體發現市場 - 主要市場動態

  • 抗體發現市場 - 主要市場動態
  • 市場促進因素
    • 增加研發投資
    • 癌症發生率上升
  • 市場限制
    • 生產成本高
  • 市場機會
    • 發展中地區生物技術產業的擴散
  • 未來的趨勢
    • 客製化抗體的開發
  • 促進因素和限制的影響：

第 6 章：抗體發現市場 - 全球市場分析

  • 抗體發現市場收入，2022-2030
  • 抗體發現市場 - 按地理位置細分，2022-2030 年

第 7 章：抗體發現市場分析 - 依抗體類型

  • 概述
  • 單株抗體
  • 多株抗體抗體
  • 其他

第 8 章：抗體發現市場分析 - 本質上

  • 概述
  • 人性化與人性化
  • 嵌合體
  • 鼠類

第 9 章：抗體發現市場分析 - 按服務

  • 概述
  • 噬菌體展示
  • 雜交瘤
  • 基因改造動物
  • 酵母展示
  • 單細胞

第 10 章：抗體發現市場分析 - 按最終用戶

  • 概述
  • 製藥和生物技術公司
  • 研究實驗室
  • 其他

第 11 章：抗體發現市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：抗體發現市場-產業格局

  • 概述
  • 抗體發現市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 13 章：公司簡介

  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Bruker Cellular Analysis Inc
  • BioDuro LLC
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • NanoCellect Biomedical Inc
  • Biocytogen Pharmaceuticals Beijing Co Ltd

第 14 章：附錄

Product Code: TIPRE00007411

The antibody discovery market size is projected to surge from US$ 2.94 billion in 2022 to US$ 4.92 billion by 2030; the market is estimated to record a CAGR of 6.7% during 2022-2030. The increasing investments in research & development and the rising incidence of cancer propel the antibody discovery market growth.

The expansion of biopharmaceutical industry, which is highly focused on biologics, results in a higher demand for antibody research services than before. Increased collaborations between industry players and academic institutions facilitate resource sharing and accelerated antibody discovery. The shift toward patient-centered drug development, emphasizing personalized medicine and patient preferences, boosts the antibody discovery market.

Continued technological advancements such as high-throughput screening, phage display, and next-generation sequencing have resulted in improved efficiency and speed of antibody discovery processes. Increased funding for research and development activities from government organizations and private companies also spurs antibody discovery initiatives. Monoclonal antibodies are gaining popularity in therapeutic applications due to their specificity and effectiveness in targeting specific antigens, resulting in increased demand for antibody research services. Therefore, the growing demand for antibody-based therapies and the preference for outsourcing are likely to have a significant impact on the antibody discovery market forecast in the next few years.

Rising Incidence of Cancer Drives the Antibody Discovery Market

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. The number of cases was significantly high in the US, China, and India. The GLOBOCAN further estimates that cancer cases in India would reach ~2.08 million by 2040, representing a rise of 57.5% from 2020. Similarly, as per the World Health Organization (WHO) data published in February 2022, ~10 million people have died from cancer worldwide. As per a report by the American Cancer Society, ~16.9 million individuals with a history of cancer have been residing in the US since January 2019. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide. Below is the list of common cancer cases reported worldwide in 2020.

  • Table 1.New Cancer Cases Worldwide, in 2020

Sr. No.Cancer TypeNumber of Cases (Million)

1Stomach1.09

2Skin (non-melanoma)1.2

3Prostate1.41

4Colon and rectum1.93

5Lung2.21

6Breast2.26

Source: World Health Organization, February 2020

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don't engage much in physical activities. The frequent consumption of alcohol and tobacco adds to the risk of developing this condition. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody-drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

Market Trend

Developments for Custom Antibodies

Antibodies are indispensable research tools that enable researchers in various scientific fields to specify, identify, localize, and quantify their protein targets. Advancements in medical technologies provide support for faster and highly efficient discoveries of antibodies that are customized as per the customers' requirements. Integrating bioinformatics in the discovery of antibodies has triggered improvements in custom antibody research. Artificial intelligence (AI) has the potential to emerge as an essential, value addition tool in the discovery of custom antibodies. AI and machine learning (ML) algorithms analyze large data sets, predict antibody-antigen interactions, and optimize antibody properties. These techniques can also aid in design, screening, and lead optimization; identify patterns; predict binding affinities; and prioritize antibody candidates for further characterization. The use of AI and ML is driven by the growing availability of big data analytics solutions and advancements in computing power, in addition to the need to efficiently analyze and interpret large-scale antibody screening data. The integration of AI and ML technologies has the potential to improve the success rates of antibody discovery projects and facilitate the development of more effective therapeutic antibodies.

The use of custom monoclonal antibodies is an attractive area in oncology research. Most of the clinical trials are performed using monoclonal antibodies derived from rabbits. For instance, anti-VEGF, a humanized anti-vascular growth endothelial factor (rabbit mAb), is currently under clinical studies for the evaluation of its effects on metastatic colorectal cancer and other solid tumors. Likewise, anti-VEGF is under clinical studies to treat age-related macular degeneration. Monoclonal antibodies derived from rabbits are proven to be a superior alternative to mouse-derived monoclonal antibodies due to a larger complementarity-determining region (CDR) in the antigen-binding site. In addition, monoclonal antibodies can be used to produce higher affinity clones. For instance, Creative Biolabs offers various custom polyclonal and monoclonal antibody production services, from gene expression or peptide synthesis to antibody purification and labeling. Therefore, custom monoclonal antibodies are likely to emerge as a profitable trend in the antibody discovery market during the forecast period.

The "Global Antibody Discovery Market" is segmented on the basis of antibody type, nature, services, end user, and geography.

Antibody Type-Based Insights

Based on product type, the antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held a larger market share in 2022. The same segment is anticipated to register a higher CAGR of 6.9% during the forecast period.

Monoclonal antibodies (mAbs) are designed to interact specifically with diseased cells without harming healthy cells. Cancer therapy is one of the significant application areas wherein monoclonal antibodies are used. These are widely accepted biologics and are expected to present high-value opportunities to pharmaceutical manufacturers during the forecast period. Moreover, awareness about the applications of mAb therapies is increasing notably among patients and physicians. As a result, the approval of blockbuster mAbs for the treatment of various indications is expected to favor the antibody discovery market growth during the forecast period. Several drugs such as Avastin, Herceptin, Remicade, and Rituxan have been approved by the FDA for cancer, rheumatoid arthritis, Crohn's disease, ulcerative colitis, etc.

End User-Based Insights

Based on end users, the antibody discovery market is segmented into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest antibody discovery market share in 2022, and the same segment is anticipated to register a higher CAGR of 7.2% during 2022-2030.

Pharmaceutical and biotechnology companies account for a significant part of the antibody discovery process because of their capabilities to identify antibodies for any specific disease and produce them on commercial scales. The elevating demand for high-specificity antibodies for drug discovery and development; growing research in the areas of proteomics and genomics; increasing need for antibodies for identifying new targets and assays; and rising R&D activities in several therapeutic areas such as cancer, HIV/AIDS, immunodeficiency diseases, and blood disorders are the critical factors driving the demand for antibody discovery products, solutions, and services in pharmaceutical and biotechnology companies.

US Food and Drug Administration, Centers for Disease Control and Prevention, Global Cancer Observatory, World Health Organization, Organization for Economic Co-operation and Development, Ministry of Health, Labour and Welfare, Ministry of Food and Drug Safety, Biomedical Advanced Research and Development Authority (BARDA) are some of the relevant sources referred while preparing the antibody discovery market research report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Antibody Discovery Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Antibody Discovery Market Landscape

  • 4.1 Overview
  • 4.2 Global PEST Analysis

5. Antibody Discovery Market - Key Market Dynamics

  • 5.1 Antibody Discovery Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Investments in Research & Development
    • 5.2.2 Rising Incidence of Cancer
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Production
  • 5.4 Market Opportunities
    • 5.4.1 Proliferation of Biotechnology Industry in Developing Regions
  • 5.5 Future Trends
    • 5.5.1 Developments for Custom Antibodies
  • 5.6 Impact of Drivers and Restraints:

6. Antibody Discovery Market - Global Market Analysis

  • 6.1 Antibody Discovery Market Revenue (US$ Million), 2022-2030
  • 6.2 Antibody Discovery Market- Breakdown by Geography, 2022-2030

7. Antibody Discovery Market Analysis - by Antibody Type

  • 7.1 Overview
  • 7.2 Monoclonal Antibodies
    • 7.2.1 Overview
    • 7.2.2 Monoclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Polyclonal Antibodies
    • 7.3.1 Overview
    • 7.3.2 Polyclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

8. Antibody Discovery Market Analysis - by Nature

  • 8.1 Overview
  • 8.2 Human and Humanized
    • 8.2.1 Overview
    • 8.2.2 Human and Humanized: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Chimeric
    • 8.3.1 Overview
    • 8.3.2 Chimeric: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Murine
    • 8.4.1 Overview
    • 8.4.2 Murine: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

9. Antibody Discovery Market Analysis - by Services

  • 9.1 Overview
  • 9.2 Phage Display
    • 9.2.1 Overview
    • 9.2.2 Phage Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Hybridoma
    • 9.3.1 Overview
    • 9.3.2 Hybridoma: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Transgenic Animal
    • 9.4.1 Overview
    • 9.4.2 Transgenic Animal: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Yeast Display
    • 9.5.1 Overview
    • 9.5.2 Yeast Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Single Cell
    • 9.6.1 Overview
    • 9.6.2 Single Cell: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

10. Antibody Discovery Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Pharmaceutical and Biotechnology Companies
    • 10.2.1 Overview
    • 10.2.2 Pharmaceutical and Biotechnology Companies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Research Laboratories
    • 10.3.1 Overview
    • 10.3.2 Research Laboratories: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Others
    • 10.4.1 Overview
    • 10.4.2 Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)

11. Antibody Discovery Market - Geographical Analysis

  • 11.1 North America Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.1.2.1 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.1.2.2 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.1.2.3 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.1.2.4 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.1.3 North America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 US
        • 11.1.3.1.1 Overview
        • 11.1.3.1.2 US: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.1.3 United States: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.1.4 United States: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.1.5 United States: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.1.6 United States: Antibody Discovery Market Breakdown, by End User
      • 11.1.3.2 Canada
        • 11.1.3.2.1 Overview
        • 11.1.3.2.2 Canada: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.2.3 Canada: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.2.4 Canada: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.2.5 Canada: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.2.6 Canada: Antibody Discovery Market Breakdown, by End User
      • 11.1.3.3 Mexico
        • 11.1.3.3.1 Overview
        • 11.1.3.3.2 Mexico: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.3.3.3 Mexico: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.1.3.3.4 Mexico: Antibody Discovery Market Breakdown, by Nature
        • 11.1.3.3.5 Mexico: Antibody Discovery Market Breakdown, by Services
        • 11.1.3.3.6 Mexico: Antibody Discovery Market Breakdown, by End User
  • 11.2 Europe Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.2.1 Overview
    • 11.2.2 Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.2.2.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.2.2.2 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.2.2.3 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.2.2.4 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.2.3 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 UK
        • 11.2.3.1.1 Overview
        • 11.2.3.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.1.4 UK: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.1.5 UK: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.1.6 UK: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.2 Germany
        • 11.2.3.2.1 Overview
        • 11.2.3.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.2.5 Germany: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.2.6 Germany: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.3 France
        • 11.2.3.3.1 Overview
        • 11.2.3.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.3.4 France: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.3.5 France: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.3.6 France: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.4 Italy
        • 11.2.3.4.1 Overview
        • 11.2.3.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.4.5 Italy: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.4.6 Italy: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.5 Spain
        • 11.2.3.5.1 Overview
        • 11.2.3.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.5.5 Spain: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.5.6 Spain: Antibody Discovery Market Breakdown, by End User
      • 11.2.3.6 Rest of Europe
        • 11.2.3.6.1 Overview
        • 11.2.3.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.3.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.2.3.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
        • 11.2.3.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
        • 11.2.3.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
  • 11.3 Asia Pacific Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.3.2.1 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.3.2.2 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.3.2.3 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.3.2.4 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.3.3 Asia Pacific: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China
        • 11.3.3.1.1 Overview
        • 11.3.3.1.2 China: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.1.4 China: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.1.5 China: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.1.6 China: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.2 Japan
        • 11.3.3.2.1 Overview
        • 11.3.3.2.2 Japan: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.2.5 Japan: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.2.6 Japan: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.3 India
        • 11.3.3.3.1 Overview
        • 11.3.3.3.2 India: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.3.4 India: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.3.5 India: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.3.6 India: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.4 Australia
        • 11.3.3.4.1 Overview
        • 11.3.3.4.2 Australia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.4.5 Australia: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.4.6 Australia: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.5 South Korea
        • 11.3.3.5.1 Overview
        • 11.3.3.5.2 South Korea: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
      • 11.3.3.6 Rest of APAC
        • 11.3.3.6.1 Overview
        • 11.3.3.6.2 Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.3.6.3 Rest of APAC: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.3.3.6.4 Rest of APAC: Antibody Discovery Market Breakdown, by Nature
        • 11.3.3.6.5 Rest of APAC: Antibody Discovery Market Breakdown, by Services
        • 11.3.3.6.6 Rest of APAC: Antibody Discovery Market Breakdown, by End User
  • 11.4 Middle East & Africa Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.4.2.1 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.4.2.2 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.4.2.3 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.4.2.4 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.4.3 Middle East & Africa: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia
        • 11.4.3.1.1 Overview
        • 11.4.3.1.2 Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.1.3 Saudi Arabia: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.1.4 Saudi Arabia: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.1.5 Saudi Arabia: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.1.6 Saudi Arabia: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.2 South Africa
        • 11.4.3.2.1 Overview
        • 11.4.3.2.2 South Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.2.3 South Africa: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.2.4 South Africa: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.2.5 South Africa: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.2.6 South Africa: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.3 UAE
        • 11.4.3.3.1 Overview
        • 11.4.3.3.2 UAE: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.3.3 UAE: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.3.4 UAE: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.3.5 UAE: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.3.6 UAE: Antibody Discovery Market Breakdown, by End User
      • 11.4.3.4 Rest of Middle East & Africa
        • 11.4.3.4.1 Overview
        • 11.4.3.4.2 Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.3.4.3 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.4.3.4.4 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Nature
        • 11.4.3.4.5 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by Services
        • 11.4.3.4.6 Rest of Middle East & Africa: Antibody Discovery Market Breakdown, by End User
  • 11.5 South & Central America Antibody Discovery Market, Revenue and Forecast To 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
      • 11.5.2.1 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Antibody Type
      • 11.5.2.2 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Nature
      • 11.5.2.3 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Services
      • 11.5.2.4 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by End User
    • 11.5.3 South & Central America: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil
        • 11.5.3.1.1 Overview
        • 11.5.3.1.2 Brazil: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.1.3 Brazil: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.1.4 Brazil: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.1.5 Brazil: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.1.6 Brazil: Antibody Discovery Market Breakdown, by End User
      • 11.5.3.2 Argentina
        • 11.5.3.2.1 Overview
        • 11.5.3.2.2 Argentina: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.2.3 Argentina: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.2.4 Argentina: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.2.5 Argentina: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.2.6 Argentina: Antibody Discovery Market Breakdown, by End User
      • 11.5.3.3 Rest of South & Central America
        • 11.5.3.3.1 Overview
        • 11.5.3.3.2 Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.3.3.3 Rest of South & Central America: Antibody Discovery Market Breakdown, by Antibody Type
        • 11.5.3.3.4 Rest of South & Central America: Antibody Discovery Market Breakdown, by Nature
        • 11.5.3.3.5 Rest of South & Central America: Antibody Discovery Market Breakdown, by Services
        • 11.5.3.3.6 Rest of South & Central America: Antibody Discovery Market Breakdown, by End User

12. Antibody Discovery Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Antibody Discovery Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Charles River Laboratories International Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Creative Biolabs Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Evotec SE
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Bruker Cellular Analysis Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 BioDuro LLC
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Sartorius AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Aragen Life Sciences Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Twist Bioscience Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 NanoCellect Biomedical Inc
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Biocytogen Pharmaceuticals Beijing Co Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Antibody Discovery Market Segmentation
  • Table 2. New Cancer Cases Worldwide, in 2020
  • Table 3. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 4. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 5. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 6. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 7. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 8. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 9. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 10. United States: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 11. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 12. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 13. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 14. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 16. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 17. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 18. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 19. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 20. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 21. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 22. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 23. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 24. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 26. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 27. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 28. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 29. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 30. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 31. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 32. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 33. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 34. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 35. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 36. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 37. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 38. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 39. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 40. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 41. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 42. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 43. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 44. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 45. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 46. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 47. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 48. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 49. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 50. Asia Pacific: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 51. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 52. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 53. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 54. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 55. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 56. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 57. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 58. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 59. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 60. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 61. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 62. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 63. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 64. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 65. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 66. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 67. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 68. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 69. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 70. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 71. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 72. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 73. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 74. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 75. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 76. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 77. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 78. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 79. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 80. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 81. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 82. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 83. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 84. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 85. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 86. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 87. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 88. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 89. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 90. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 91. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 92. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 93. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 94. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 95. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 96. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 97. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 98. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 99. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 100. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 101. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 102. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 103. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 104. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 105. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 106. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 107. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
  • Table 108. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
  • Table 109. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
  • Table 110. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 111. Recent Inorganic Growth Strategies in the Antibody Discovery Market
  • Table 112. Recent Organic Growth Strategies in the Antibody Discovery Market
  • Table 113. Glossary of Terms, Antibody Discovery Market

List Of Figures

  • Figure 1. Antibody Discovery Market Segmentation, by Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Antibody Discovery Market Revenue (US$ Million), 2022 - 2030
  • Figure 5. Antibody Discovery Market Breakdown by Geography, 2022 and 2030 (%)
  • Figure 6. Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
  • Figure 7. Monoclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Polyclonal Antibodies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
  • Figure 11. Human and Humanized: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Chimeric: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Murine: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Antibody Discovery Market Share (%) - by Services (2022 and 2030)
  • Figure 15. Phage Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hybridoma: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Transgenic Animal: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Yeast Display: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Single Cell: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Antibody Discovery Market Share (%) - by End User (2022 and 2030)
  • Figure 21. Pharmaceutical and Biotechnology Companies: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Research Laboratories: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Others: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 25. North America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 26. North America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. US: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 31. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 33. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 34. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Asia Pacific: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 40. Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 41. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 42. China: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 43. Japan: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 44. India: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 45. Australia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 46. South Korea: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 47. Rest of APAC: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 48. Middle East & Africa: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 49. Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 50. Middle East & Africa: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 51. Saudi Arabia: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 52. South Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 53. UAE: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 54. Rest of Middle East & Africa: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 55. South & Central America: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 56. South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 57. South & Central America: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 58. Brazil: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 59. Argentina: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 60. Rest of South & Central America: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 61. Growth Strategies in the Antibody Discovery Market